Highlights
- 1Frontiers in neurology · 2023
Publications
29 publications
Funding
3 grants
Active
1 grant- MPIR01AG076634-03Phase II randomized controlled trial of benfotiamine in early Alzheimer's DiseaseNational Institute on Aging · 2022–2026 · via University of California, San Diego
Completed grants (2)
- Co-IR01AG072753-01A1Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2021–2024
- Co-IU24NS107168-01Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)National Institute of Neurological Disorders and Stroke · 2018–2023 · via Columbia University
Clinical research
2 studies
Active
2 studies- PINCT06223360A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo- Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)PHASE2 · Winifred Masterson Burke Medical Research · OPEN TO ACCRUAL (as of 2024)Alzheimer Disease
- PIWeill Cornell Medicine Cognition Database - BRANYplus transferWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2022)
News mentions
1 mentionView all WCM news ↗
- Decades of Work Leads to Clinical Trial for Early Alzheimer’s TreatmentDecember 19, 2024
After years of research, Dr. Gary Gibson’s work has culminated in a nationwide clinical trial evaluating an entirely new treatment approach for slowing Alzheimer’s progression.
Media highlights
2 clips
- Avoiding These Three Vascular Health Risk Factors In Midlife Can Help You Delay Dementia For About 13 Years, Study SuggestsSmithsonian Magazine · August 18, 2026
- How 3 Health Factors Can Help Delay Dementia For Up To 13 YearsWNBC-TV (New York, NY) · August 11, 2026
Mentoring
1 menteeAll publications with mentees →
- DMDarby MarxMD mentee · Class of 2025